PAI-1 gene therapy (UT SouthWestern)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePAI-1 gene therapy (UT SouthWestern)
Drug Alias Namemelanoma gene therapy (University of Texas)gene therapy (University of Texas)
ClassificationBiologics
Mechanisms of ActionPlasminogen activators inhibitors
TargetsPlasminogen activators
Therapy Area/IndicationsUveal melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical Center
Active IndicationsN/A
Inactive IndicationsUveal melanoma

Other Information

ATC CodeN/A
Related LinksN/A